Title Mitofusin 2 gene mutation causing early-onset CMT2A with different progressive courses
Authors Lv, He
Wang, Lu
Li, Wurong
Qiao, Xiaohui
Li, Yuexing
Wang, Zhaoxia
Yuan, Yun
Affiliation Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China.
Peking Univ, Hosp 1, Dept Neurol, 8 Xishiku St, Beijing 100034, Peoples R China.
Keywords mitofusin 2(MFN2)
Charcot-Marie-Tooth 2A2(CMT2A2)
optic atrophy
neuropathology
gene mutation
MARIE-TOOTH DISEASE
MFN2 MUTATIONS
NEUROPATHY
TYPE-2
FAMILIES
FEATURES
Issue Date 2013
Publisher clinical neuropathology
Citation CLINICAL NEUROPATHOLOGY.2013,32,(1),16-23.
Abstract Charcot-Marie-Tooth disease Type 2A2 (CMT2A2), caused by mitofusin 2 (MFN2) genes, has been clinically classified into two types: severe early-onset and mild benign. Here we reported 3 early onset patients with different progressive courses. The 3 patients had mutations R94W, R364W and a novel W740R in the MFN2 gene. Two patients presented with progressive distal limb muscle weakness and wasting from the ages of 5 and 6 years, respectively. The disease developed slowly, with loss of ambulation after 35 years of age. The third patient presented with similar symptoms afterbirth, and has never been able to walk independently. Sural nerve biopsies revealed severe axonal neuropathy with mitochondrial aggregation in axons. Our data confirmed that early-onset CMT2A2 can present with different courses in Chinese patients. The novel mutation in MFN2 found in this study broadens the genotypic spectrum associated with MFN2 related CMT.
URI http://hdl.handle.net/20.500.11897/304262
ISSN 0722-5091
DOI 10.5414/NP300464
Indexed SCI(E)
PubMed
Appears in Collections: 第一医院

Files in This Work
There are no files associated with this item.

Web of Science®


8

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.